Thelansis

 Basal Cell Carcinoma (BCC) (also called basal cell skin cancer) is generally defined as a locally invasive, slowly spreading tumor that rarely metastasizes, arising in the epidermis or hair follicles. The main etiological factor responsible for BCC is chronic UV exposure at the expense mostly of UVB rays with a length of 290-320 mm. This results in activating proto-oncogenes and inactivating tumor-suppressive genes in the keratinocytes. ·        Basal Cell Carcinoma (BCC) is quite common, and the number of reported cases in the U.S. has steadily increased. The incidence of BCC is about 2000 cases per 100 000 population. More than 4 million Americans are diagnosed with BCC each year.   Thelansis’s “Basal Cell Carcinoma (BCC) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practi...

 Basal Cell Carcinoma (BCC) (also called basal cell skin cancer) is generally defined as a locally invasive, slowly spreading tumor that rarely metastasizes, arising in the epidermis or hair follicles. The main etiological factor responsible for BCC is chronic UV exposure at the expense mostly of UVB rays with a length of 290-320 mm. This results in activating proto-oncogenes and inactivating tumor-suppressive genes in the keratinocytes. ·        Basal Cell Carcinoma (BCC) is quite common, and the number of reported cases in the U.S. has steadily increased. The incidence of BCC is about 2000 cases per 100 000 population. More than 4 million Americans are diagnosed with BCC each year. Thelansis’s “Basal Cell Carcinoma (BCC) Market Outlook, Epidemiology , Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, reg...